Syndicate This week's upcoming IPO's and secondary offerings

Week of March 19 to March 23, 2024

This Week's Deals to be Priced

03/20 - Tuesday

Symbol

Issuer

Type

Price

Managers

PTI

Proteostasis
Proteostasis
Secondary
Cancelled $6.99
9M
Leerink & RBC Capital

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Leerink & RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

03/22 - Thursday

Symbol

Issuer

Type

Price

Managers

POLY

PolyPid
PolyPid
IPO
Postponed $21.00-24.00
3.33M
Goldman Sachs & TD Cowen,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & TD Cowen, Cantor Fitzgerald, Raymond James, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NOG

Northern Oil and Gas
Northern Oil and Gas
Secondary
Postponed $2.30

Stifel

Pricing after close
Deal analysis and details

Managers: Stifel

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

03/20 - Tuesday

Symbol

Issuer

Type

Price

Managers

VYGR

Voyager Therapeutics
Voyager Therapeutics
Block Trade
Priced: $20.25
1M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CISN

Cision
Cision
Secondary
Priced: $10.75
5.75M
JPMorgan & Deutsche Bank,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & Deutsche Bank, Credit Suisse, RBC Capital, Baird, Barclays, BMO Capital, SUNT, CJS Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FSCT

ForeScout
ForeScout
Secondary
Priced: $29.00
4.41M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, JPMorgan & Citi, UBS, KeyBanc, Stephens

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GLYC

GlycoMimetics
GlycoMimetics
Secondary
Priced: $17.00
7M
Jefferies & TD Cowen

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
XNCR

Xencor
Xencor
Secondary
Priced: $31.00
7.3M
Leerink & Piper Sandler

Pricing after close
Deal analysis and details

Managers: Leerink & Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DBVT

DBV Technologies
DBV Technologies
Spot Secondary
Priced: $21.26
3.528M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, Goldman Sachs, Barclays & Deutsche Bank

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TSLX

TPG Specialty Lending
TPG Specialty Lending
Spot Secondary
Priced: $17.45
3.75M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Wells Fargo, BofA, Morgan Stanley, Raymond James, Keefe Bruyette, RBC Capital, Goldman Sachs & Citi, Janney Montgomery Scott, JMP Securities, Ladenburg, Comerica, Grupo Santander, Mizuho, TPG Capital, HSBC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

03/21 - Wednesday

Symbol

Issuer

Type

Price

Managers

ARNA

Arena Pharmaceuticals
Arena Pharmaceuticals
Secondary
Priced: $41.50
8.5M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Leerink, Cantor Fitzgerald, Credit Suisse & RBC Capital, Guggenheim, JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GAIA

Gaia
Gaia
Spot Secondary
Priced: $15.00
2.333M
B. Riley,...

Pricing after close
Deal analysis and details

Managers: B. Riley, Lake Street, DOTC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

03/22 - Thursday

Symbol

Issuer

Type

Price

Managers

DBX

Dropbox
Dropbox
IPO
Priced: $21.00
36M
Goldman Sachs & JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs & JPMorgan, Deutsche Bank, Allen & Co., BofA, RBC Capital, Jefferies, Macquarie, Canaccord, JMP Securities, KeyBanc, Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
STG

Sunlands Online
Sunlands Online
IPO
Priced: $11.50
13M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, JPMorgan & Credit Suisse, CLSA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RESN

Resonant
Resonant
Secondary
Priced: $3.50
5.714M
Needham

Pricing after close
Deal analysis and details

Managers: Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AKBA

Akebia
Akebia
Spot Secondary
Priced: $10.50
8.5M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LPTX

Leap Therapeutics
Leap Therapeutics
Spot Secondary
Priced: $7.50
1.87M
Raymond James & Ladenburg

Pricing after close
Deal analysis and details

Managers: Raymond James & Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access